Military Testosterone Screening: What Physicians Need to Know

Military Testosterone Screening: Understanding the Clinical Framework

Pete Hegseth's announcement of mandatory testosterone screening for U.S. military service members over 30 represents a significant institutional pivot toward endocrine optimization in performance contexts. As physicians, we should understand the clinical implications, testing protocols, and what constitutes defensible therapeutic ranges—not marketing ranges.

The Policy Mechanics

The DoD directive mandates annual testosterone level assessment for service members aged 30 and older, with optional testosterone replacement therapy (TRT) offered to those meeting deficiency criteria. This is institutional-scale hormone optimization policy. The stated rationale centers on combat readiness and what Hegseth termed "leading edge of lethality," but the underlying mechanism is straightforward: testosterone influences muscle mass, bone density, cognitive function, and metabolic rate.

What "Low Testosterone" Actually Means Clinically

Here's where precision matters. Reference ranges vary by lab, but most define hypogonadism as total testosterone <300 ng/dL. However, optimal functional ranges differ from deficiency thresholds.

Total vs. Free Testosterone: Total testosterone includes both bioavailable and SHBG-bound hormone. Free testosterone (2-5% of total) is metabolically active. A service member with total testosterone of 450 ng/dL but elevated SHBG may have inadequate free testosterone despite a "normal" total. Order both.

The Testosterone Panel Should Include:

• Total testosterone (morning draw, fasting preferred)
• Free testosterone (calculated or direct assay)
• SHBG (sex hormone-binding globulin)
• Estradiol (ultrasensitive, LC-MS)
• LH/FSH (to differentiate primary vs. secondary hypogonadism)
• PSA (baseline, mandatory before TRT initiation)
• Hematocrit/hemoglobin (testosterone elevates RBC production)

Baseline Testing Before Any Intervention

The DoD protocol should mandate—and forward-thinking clinicians will insist on—comprehensive baseline labs:

Metabolic & Endocrine: Fasting glucose, insulin, HbA1c, lipid panel (testosterone affects lipid metabolism), thyroid panel (TSH, free T3, free T4), cortisol (morning and evening), DHEA-S.

Cardiovascular Risk: High-sensitivity CRP, Lp(a), apoB if available.

Hematology: CBC (baseline hemoglobin critical; testosterone can drive polycythemia).

Liver/Renal Function: AST, ALT, creatinine, BUN (TRT can stress both).

Micronutrient Status: Magnesium (RBC magnesium if possible), zinc, vitamin D25-OH, B12, folate.

Without baselines, you cannot distinguish TRT-induced changes from pre-existing pathology. You also cannot justify dose escalation.

Optimal Ranges vs. Reference Ranges

Laboratories define reference ranges (usually 2.5th to 97.5th percentile of the population tested). These are not optimal ranges. For military-age service members seeking performance and health optimization, consider:

Total Testosterone: 500-1000 ng/dL (upper half of "normal" or modest physiologic replacement) Free Testosterone: 10-25 pg/mL (depends on assay; check your lab's coefficients) Estradiol: 20-30 pg/mL (too high increases cardiovascular and thromboembolic risk; too low impairs bone health and mood) SHBG: 25-50 nM/L (elevated SHBG reduces bioavailable hormone)

Servicemen with baseline testosterone at 350 ng/dL and symptoms (fatigue, reduced recovery, mood flatness) may benefit from TRT to reach 600-700 ng/dL. Those at 450 ng/dL with normal free testosterone and no symptoms do not.

Synergistic Interventions Before or Alongside TRT

Not every low-testosterone case requires pharmaceutical hormone replacement. Physicians should optimize foundational inputs first:

Magnesium Glycinate: 400-500 mg daily. Magnesium is a cofactor in SHBG synthesis and supports testosterone production. Low magnesium impairs sleep quality, which suppresses testosterone.

Zinc: 15-30 mg daily (not >40 mg chronically). Zinc is essential for LH synthesis and testicular testosterone production. Deficiency is common in military populations with high training stress.

Vitamin D3/K2: Vitamin D insufficiency (<30 ng/mL 25-OH-D) correlates with lower testosterone. Target 40-60 ng/mL. Vitamin K2 (MK-7, 180 mcg daily) supports bone mineral density—critical given testosterone's role in bone remodeling.

Omega-3 (EPA/DHA): 2-3 grams daily combined EPA+DHA. Supports cardiovascular health and may improve insulin sensitivity (hyperinsulinemia elevates SHBG).

Ashwagandha (KSM-66): 300-600 mg daily in divided doses. Reduces cortisol. Elevated cortisol suppresses testosterone via axis antagonism. Several RCTs show ashwagandha modestly elevates testosterone and reduces SHBG.

Creatine Monohydrate: 5 grams daily. Supports ATP availability and may amplify testosterone's anabolic effects. Well-researched in military populations.

Monitoring Protocol on TRT

If TRT is initiated:

• Repeat labs at 6 weeks: Testosterone, free testosterone, estradiol, hematocrit, lipids, PSA.
• Then quarterly: Repeat testosterone, estradiol, hematocrit, PSA until stable; annually thereafter.
• Adjust dose based on labs and symptoms, not just testosterone numbers. A service member at 800 ng/dL feeling well is not undertreated.

Safety Considerations

Testosterone therapy is not benign. Risks include polycythemia (elevated RBCs, increased clotting risk), gynecomastia (if estradiol creeps high), acne, mood instability, suppressed endogenous LH/FSH, and potential cardiovascular effects in men with pre-existing atherosclerosis. Sleep apnea worsens. Prostate must be monitored.

The DoD's optional TRT model is clinically sound—it acknowledges that screening without intervention is mere data collection. But every service member offered TRT must understand contraindications and commit to monitoring.

Bottom Line

The military's testosterone screening initiative signals institutional recognition that hormone optimization improves performance. But for physicians, this is a reminder: screening without protocol-driven follow-up, baseline biomarkers, and individualized dosing is theater. Insist on comprehensive panels, establish true baselines, and distinguish between deficiency (requiring treatment) and suboptimal levels in asymptomatic men (requiring optimization of sleep, stress, nutrition, and micronutrients first). Testosterone is powerful. Use it judiciously.

Disclaimer: This content is for educational purposes only and does not constitute medical advice.